Therefore, vitamin D analogs have been suggested to be used as renin inhibitors similar to ACE inhibitors and ARBs for patients with hyperreninemia, which can benefit patients with metabolic syndrome and/or hypertension [25]. The gene discussed is REN; the disease is metabolic syndrome.